MaxCyte, Inc. Filing of Form 10-Q for Second Quarter (6259V)
August 11 2022 - 2:00AM
UK Regulatory
TIDMMXCT TIDMTTM
RNS Number : 6259V
MaxCyte, Inc.
11 August 2022
MaxCyte announces filing of Form 10-Q for the quarterly period
ended June 30, 2022
ROCKVILLE, MD, August 11, 2022 - MaxCyte, Inc., (NASDAQ: MXCT;
LSE: MXCT), a leading commercial cell-engineering company focused
on providing enabling platform technologies to advance innovative
cell-based research as well as next-generation cell therapeutic
discovery, development and commercialization , today announced that
it has filed a Form 10-Q with the SEC for the quarterly period
ended June 30, 2022.
A copy of the Form 10-Q is available to view on the SEC's
website at www.sec.gov and has also been posted to the "SEC
filings" page of the Company's website,
https://investors.maxcyte.com/.
MaxCyte Contacts:
US IR Adviser +1 415-937-5400
ir@maxcyte.com
Gilmartin Group
David Deuchler, CFA
US Media Relations
Seismic
Valerie Enes
Nominated Adviser and Joint Corporate Broker +1 408-497-8568
Panmure Gordon
Emma Earl / Freddy Crossley
Corporate Broking
Rupert Dearden +44 (0)20 7886 2500
UK IR Adviser
Consilium Strategic Communications +44 (0)203 709 5700
Mary-Jane Elliott maxcyte@consilium-comms.com
Chris Welsh
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCURVNRURUWAAR
(END) Dow Jones Newswires
August 11, 2022 02:00 ET (06:00 GMT)
Maxcyte (LSE:MXCT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Maxcyte (LSE:MXCT)
Historical Stock Chart
From Jul 2023 to Jul 2024